Immunovant Stock Investor Trims Stake, Still Bullish
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Knowing what not to do as a new investor can save you time and money. Avoid common mistakes to build a successful investment portfolio.
27,924 articlesImmunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
A local resident faced a costly trap when a counterfeit permit message appeared to be the next step in the process. T...
Travel rewards can feel like extra money in your pocket, but taxes can complicate the picture. This guide explains wh...
A big fund move can shift sentiment and pricing. This article breaks down the implications of baillie gifford dumps 2...
Big-name bets via 13F filings often reveal more about risk management than marketing hype. This quarter, billionaire ...
A senior executive at Ziff Davis sold a sizable block of shares. This article dives into what that move could mean fo...
A major policy move in Japan raised rates to a level not seen in decades, but the crypto market barely moved. Learn w...
Tech founder moves set a high bar for OpenAI's IPO. This article breaks down the reality behind altman called openai ...
Investors often chase growth or income. When Enbridge trades under $60, a thoughtful plan can unlock both. This guide...
When Warren Buffett's successor Greg Abel took the helm, Berkshire Hathaway signaled a new phase. This article breaks...
Retail investors often wonder if congressional trades offer investing clues. This guide explains what "members congre...
When big funds hold IonQ, retail investors often assume a sure bet. The reality is more nuanced: ownership data refle...